ArticleCommunications biology2020

Targeting endothelin 1 receptor-miR-200b/c-ZEB1 circuitry blunts metastatic progression in ovarian cancer.

Rosanna Sestito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.